Walleye Trading’s Coeptis Therapeutics Warrants COEPW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-79,942
| Closed | -$927 | – | 4045 |
|
|
2026
Q1 | $927 | Hold |
79,942
| – | – | ﹤0.01% | 4020 |
|
|
2025
Q4 | $863 | Hold |
79,942
| – | – | ﹤0.01% | 4235 |
|
|
2025
Q3 | $2.1K | Sell |
79,942
-50,230
| -39% | -$1.33K | ﹤0.01% | 4274 |
|
|
2025
Q2 | $3.75K | Sell |
130,172
-1,100
| -0.8% | -$24 | ﹤0.01% | 4107 |
|
|
2025
Q1 | $1.42K | Sell |
131,272
-2,909
| -2% | -$76 | ﹤0.01% | 3941 |
|
|
2024
Q4 | $2.95K | Buy |
134,181
+61,621
| +85% | +$1.47K | ﹤0.01% | 4105 |
|
|
2024
Q3 | $1.09K | Hold |
72,560
| – | – | ﹤0.01% | 3975 |
|
|
2024
Q2 | $2.18K | Hold |
72,560
| – | – | ﹤0.01% | 4057 |
|
|
2024
Q1 | $1.85K | Hold |
72,560
| – | – | ﹤0.01% | 4533 |
|
|
2023
Q4 | $2.25K | Hold |
72,560
| – | – | ﹤0.01% | 4812 |
|
|
2023
Q3 | $1.64K | Hold |
72,560
| – | – | ﹤0.01% | 4807 |
|
|
2023
Q2 | $5.2K | Hold |
72,560
| – | – | ﹤0.01% | 4344 |
|
|
2023
Q1 | $10.7K | Hold |
72,560
| – | – | ﹤0.01% | 4355 |
|
|
2022
Q4 | $7.25K | Buy |
72,560
+360
| +0.5% | +$24 | ﹤0.01% | 4530 |
|
|
2022
Q3 | $2K | Hold |
72,200
| – | – | ﹤0.01% | 4791 |
|
|
2022
Q2 | $3K | Buy |
72,200
+14,000
| +24% | +$1.05K | ﹤0.01% | 4875 |
|
|
2022
Q1 | $5K | Hold |
58,200
| – | – | ﹤0.01% | 5098 |
|
|
2021
Q4 | $19K | Hold |
58,200
| – | – | ﹤0.01% | 4943 |
|
|
2021
Q3 | $15K | Hold |
58,200
| – | – | ﹤0.01% | 4930 |
|
|
2021
Q2 | $31K | Hold |
58,200
| – | – | ﹤0.01% | 4749 |
|
|
2021
Q1 | $25K | Buy |
58,200
+8,000
| +16% | +$7.51K | ﹤0.01% | 4496 |
|
|
2020
Q4 | $69K | Buy |
+50,200
| New | +$46.3K | ﹤0.01% | 4075 |
|
Other funds holding COEPW
Walleye Trading's COEPW Position: Q2 2026 in Review
Walleye Trading sold out of Coeptis Therapeutics Warrants (COEPW) in Q2 2026, closing a stake of 79,942 shares — an estimated $927 sold.
Walleye Trading first reported a position in COEPW in Q4 2020 and held it in 22 quarters. The position peaked at $69K in Q4 2020. 3 funds tracked by Wall St. Rank hold COEPW as of Q2 2026.
- Walleye Trading reported no remaining Coeptis Therapeutics Warrants position as of Q2 2026 after selling out during the quarter.
- Walleye Trading sold 79,942 Coeptis Therapeutics Warrants shares in Q2 2026, an estimated $927.
- Walleye Trading first reported a position in Coeptis Therapeutics Warrants in Q4 2020 and held it in 22 quarters.
- Walleye Trading's Coeptis Therapeutics Warrants position peaked at $69K in Q4 2020.
- 3 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q2 2026.
Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.